These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18635818)

  • 1. Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding.
    Dorfmeister B; Zeng WW; Dichlberger A; Nilsson SK; Schaap FG; Hubacek JA; Merkel M; Cooper JA; Lookene A; Putt W; Whittall R; Lee PJ; Lins L; Delsaux N; Nierman M; Kuivenhoven JA; Kastelein JJ; Vrablik M; Olivecrona G; Schneider WJ; Heeren J; Humphries SE; Talmud PJ
    Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1866-71. PubMed ID: 18635818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis.
    Schaap FG; Rensen PC; Voshol PJ; Vrins C; van der Vliet HN; Chamuleau RA; Havekes LM; Groen AK; van Dijk KW
    J Biol Chem; 2004 Jul; 279(27):27941-7. PubMed ID: 15090553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase.
    Merkel M; Loeffler B; Kluger M; Fabig N; Geppert G; Pennacchio LA; Laatsch A; Heeren J
    J Biol Chem; 2005 Jun; 280(22):21553-60. PubMed ID: 15774484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride.
    Buonuomo PS; Rabacchi C; Macchiaiolo M; Trenti C; Fasano T; Tarugi P; Bartuli A; Bertolini S; Calandra S
    J Clin Lipidol; 2017; 11(6):1329-1337.e3. PubMed ID: 28951076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional importance of apolipoprotein A5 185G in the activation of lipoprotein lipase.
    Huang YJ; Lin YL; Chiang CI; Yen CT; Lin SW; Kao JT
    Clin Chim Acta; 2012 Jan; 413(1-2):246-50. PubMed ID: 22008704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Variants Associated with Gestational Hypertriglyceridemia and Pancreatitis.
    Xie SL; Chen TZ; Huang XL; Chen C; Jin R; Huang ZM; Zhou MT
    PLoS One; 2015; 10(6):e0129488. PubMed ID: 26079787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency.
    Calandra S; Priore Oliva C; Tarugi P; Bertolini S
    Curr Opin Lipidol; 2006 Apr; 17(2):122-7. PubMed ID: 16531747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare and common variants in LPL and APOA5 in Thai subjects with severe hypertriglyceridemia: A resequencing approach.
    Khovidhunkit W; Charoen S; Kiateprungvej A; Chartyingcharoen P; Muanpetch S; Plengpanich W
    J Clin Lipidol; 2016; 10(3):505-511.e1. PubMed ID: 27206937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia.
    Surendran RP; Visser ME; Heemelaar S; Wang J; Peter J; Defesche JC; Kuivenhoven JA; Hosseini M; Péterfy M; Kastelein JJ; Johansen CT; Hegele RA; Stroes ES; Dallinga-Thie GM
    J Intern Med; 2012 Aug; 272(2):185-96. PubMed ID: 22239554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient lowering of triglyceride levels in mice by human apoAV protein variants associated with hypertriglyceridemia.
    Vaessen SF; Sierts JA; Kuivenhoven JA; Schaap FG
    Biochem Biophys Res Commun; 2009 Feb; 379(2):542-6. PubMed ID: 19121291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of phenotypic expression of APOA5 Q97X and L242P mutations.
    Charrière S; Cugnet C; Guitard M; Bernard S; Groisne L; Charcosset M; Pruneta-Deloche V; Merlin M; Billon S; Delay M; Sassolas A; Moulin P; Marçais C
    Atherosclerosis; 2009 Nov; 207(1):150-6. PubMed ID: 19447388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and functional characterization of a novel heterozygous missense variant in the LPL associated with recurrent hypertriglyceridemia-induced acute pancreatitis in pregnancy.
    Shi XL; Yang Q; Pu N; Li XY; Chen WW; Zhou J; Li G; Tong ZH; Férec C; Cooper DN; Chen JM; Li WQ
    Mol Genet Genomic Med; 2020 Mar; 8(3):e1048. PubMed ID: 31962008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study.
    Ariza MJ; Sánchez-Chaparro MA; Barón FJ; Hornos AM; Calvo-Bonacho E; Rioja J; Valdivielso P; Gelpi JA; González-Santos P
    BMC Med Genet; 2010 Apr; 11():66. PubMed ID: 20429872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment.
    Marçais C; Verges B; Charrière S; Pruneta V; Merlin M; Billon S; Perrot L; Drai J; Sassolas A; Pennacchio LA; Fruchart-Najib J; Fruchart JC; Durlach V; Moulin P
    J Clin Invest; 2005 Oct; 115(10):2862-9. PubMed ID: 16200213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein lipase activity determined in vivo is lower in carriers of apolipoprotein A-V gene variants 19W and -1131C.
    Kovář J; Adámková V
    Physiol Res; 2008; 57(4):555-561. PubMed ID: 17705673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia.
    Priore Oliva C; Pisciotta L; Li Volti G; Sambataro MP; Cantafora A; Bellocchio A; Catapano A; Tarugi P; Bertolini S; Calandra S
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):411-7. PubMed ID: 15591215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New rare genetic variants of LMF1 gene identified in severe hypertriglyceridemia.
    Serveaux Dancer M; Di Filippo M; Marmontel O; Valéro R; Piombo Rivarola MDC; Peretti N; Caussy C; Krempf M; Vergès B; Mahl M; Marçais C; Moulin P; Charrière S
    J Clin Lipidol; 2018; 12(5):1244-1252. PubMed ID: 30037590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous injection of apolipoprotein A-V reconstituted high-density lipoprotein decreases hypertriglyceridemia in apoav-/- mice and requires glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1.
    Shu X; Nelbach L; Weinstein MM; Burgess BL; Beckstead JA; Young SG; Ryan RO; Forte TM
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2504-9. PubMed ID: 20966404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects.
    Di Filippo M; Marçais C; Charrière S; Marmontel O; Broyer M; Delay M; Merlin M; Nollace A; Valéro R; Lagarde M; Pruneta-Deloche V; Moulin P; Sassolas A
    PLoS One; 2014; 9(6):e99721. PubMed ID: 24886863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of chylomicronemia in a clinical laboratory setting: diagnosis of 13 cases of lipoprotein lipase deficiency.
    Martín-Campos JM; Julve J; Roig R; Martínez S; Errico TL; Martínez-Couselo S; Escolà-Gil JC; Méndez-González J; Blanco-Vaca F
    Clin Chim Acta; 2014 Feb; 429():61-8. PubMed ID: 24291057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.